Peregrine Capital Management’s SpringWorks Therapeutics SWTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-157,671
| Closed | -$6.96M | – | 343 |
|
|
2025
Q1 | $6.96M | Sell |
157,671
-3,515
| -2% | -$155K | 0.23% | 124 |
|
|
2024
Q4 | $5.82M | Sell |
161,186
-4,348
| -3% | -$157K | 0.17% | 188 |
|
|
2024
Q3 | $5.3M | Buy |
165,534
+28,971
| +21% | +$928K | 0.16% | 208 |
|
|
2024
Q2 | $5.14M | Buy |
136,563
+19,915
| +17% | +$750K | 0.15% | 226 |
|
|
2024
Q1 | $5.74M | Sell |
116,648
-19,361
| -14% | -$953K | 0.16% | 214 |
|
|
2023
Q4 | $4.96M | Sell |
136,009
-23,469
| -15% | -$857K | 0.15% | 228 |
|
|
2023
Q3 | $3.69M | Sell |
159,478
-10,015
| -6% | -$232K | 0.11% | 239 |
|
|
2023
Q2 | $4.44M | Sell |
169,493
-50
| -0% | -$1.31K | 0.12% | 244 |
|
|
2023
Q1 | $4.36M | Buy |
169,543
+5,002
| +3% | +$129K | 0.13% | 241 |
|
|
2022
Q4 | $4.28M | Buy |
+164,541
| New | +$4.28M | 0.13% | 239 |
|